DECADenali Capital Acquisition Corp - Ordinary Shares - Class A

$4.89
$1.79
(57.74%)
Today
Updated: 02:11 PM EDT
Mkt Cap$1.13B
Vol502.00
News
all
press releases
News Placeholder
Scilex Subsidiary Semnur Pharma Eyes $20M Private Placement Deal: More Details Inside
The proceeds of the agreement will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural injections, for the treatment of lumbosacral radicular pain.
Stocktwits
News Placeholder
Small-Cap Scilex Drew Biggest Jump In Retail Following For July: What Drove It?
Retail investors flocked to Scilex, drawn by news about a lucrative SPAC deal for its unit, declining cash reserves and slowing sales growth.
Stocktwits
<
...
1
>

Advertisement|Remove ads.